• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脂肪肝的无创评估]

[Non-invasive assessment of fatty liver].

作者信息

Egresi Anna, Lengyel Gabriella, Hagymási Krisztina

机构信息

Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088.

出版信息

Orv Hetil. 2015 Apr 5;156(14):543-51. doi: 10.1556/OH.2015.30123.

DOI:10.1556/OH.2015.30123
PMID:25819147
Abstract

As the result of various harmful effects (infectious agents, metabolic diseases, unhealthy diet, obesity, toxic agents, autoimmune processes) hepatic damage may develop, which can progress towards liver steatosis, and fibrosis as well. The most common etiological factors of liver damages are hepatitis B and C infection, alcohol consumption and non-alcoholic fatty liver disease. Liver biopsy is considered as the gold standard for the diagnosis of chronic liver diseases. Due to the dangers and complications of liver biopsy, studies are focused on non-invasive markers and radiological imaging for liver steatosis, progression of fatty liver, activity of the necroinflammation and the severity of the fibrosis. Authors review the possibilities of non-invasive assessment of liver steatosis. The statistical features of the probes (positive, negative predictive values, sensitivity, specificity) are reviewed. The role of radiological imaging is also discussed. Although the non-invasive methods discussed in this article are useful to assess liver steatosis, further studies are needed to validate to follow progression of the diseases and to control therapeutic response.

摘要

由于各种有害影响(感染因子、代谢性疾病、不健康饮食、肥胖、有毒物质、自身免疫过程),可能会发生肝损伤,进而可能发展为肝脂肪变性和肝纤维化。肝损伤最常见的病因是乙型和丙型肝炎感染、饮酒以及非酒精性脂肪性肝病。肝活检被认为是诊断慢性肝病的金标准。由于肝活检存在风险和并发症,研究主要集中在用于评估肝脂肪变性、脂肪肝进展、坏死性炎症活动度以及肝纤维化严重程度的非侵入性标志物和放射影像学检查。作者回顾了非侵入性评估肝脂肪变性的可能性。文中回顾了各项检测指标的统计学特征(阳性预测值、阴性预测值、敏感性、特异性)。还讨论了放射影像学检查的作用。尽管本文讨论的非侵入性方法对于评估肝脂肪变性很有用,但仍需要进一步研究以验证其在跟踪疾病进展和监测治疗反应方面的有效性。

相似文献

1
[Non-invasive assessment of fatty liver].[脂肪肝的无创评估]
Orv Hetil. 2015 Apr 5;156(14):543-51. doi: 10.1556/OH.2015.30123.
2
[Options for non-invasive assessment of liver fibrosis based on clinical data].基于临床数据的肝纤维化无创评估方法
Orv Hetil. 2015 Jan 11;156(2):43-52. doi: 10.1556/OH.2015.30069.
3
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.使用受控衰减参数(CAP)和瞬时弹性成像技术进行非侵入性诊断肝脂肪变性。
Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.
4
Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.安大略省使用瞬时弹性成像和受控衰减参数诊断肝纤维化和脂肪变性的经济学分析
Ont Health Technol Assess Ser. 2015 Nov 1;15(19):1-58. eCollection 2015.
5
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.超声脂肪肝指标可检测轻度脂肪变性,并与各种肝脏疾病的代谢/组织学参数相关。
Metabolism. 2017 Jul;72:57-65. doi: 10.1016/j.metabol.2017.04.003. Epub 2017 Apr 13.
6
Non-invasive diagnosis of steatosis and fibrosis.脂肪变性和纤维化的非侵入性诊断
Diabetes Metab. 2008 Dec;34(6 Pt 2):674-9. doi: 10.1016/S1262-3636(08)74603-2.
7
Hepatic steatosis in obese Chinese children.肥胖中国儿童的肝脂肪变性
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1257-63. doi: 10.1038/sj.ijo.0802734.
8
Review article: Non-alcoholic fatty liver disease.综述文章:非酒精性脂肪性肝病
Aliment Pharmacol Ther. 2003 Apr;17(8):977-86. doi: 10.1046/j.1365-2036.2003.01493.x.
9
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.用于非酒精性脂肪性肝病中脂肪变性诊断的受控衰减参数
J Gastroenterol Hepatol. 2016 Apr;31(4):848-55. doi: 10.1111/jgh.13219.
10
Pathology and biopsy assessment of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的病理学和活检评估。
Dig Dis. 2010;28(1):197-202. doi: 10.1159/000282086. Epub 2010 May 7.

引用本文的文献

1
Shu Fu Pai Protein Short Peptides Beverage for the treatment of hypoalbuminemia in liver cirrhosis.舒腹牌蛋白质短肽饮料用于治疗肝硬化低白蛋白血症。
Am J Transl Res. 2023 Sep 15;15(9):5723-5729. eCollection 2023.